Literature DB >> 24331795

Optic neuritis.

Ahmed T Toosy1, Deborah F Mason2, David H Miller3.   

Abstract

Acute optic neuritis is the most common optic neuropathy affecting young adults. Exciting developments have occurred over the past decade in understanding of optic neuritis pathophysiology, and these developments have been translated into treatment trials. In its typical form, optic neuritis presents as an inflammatory demyelinating disorder of the optic nerve, which can be associated with multiple sclerosis. Atypical forms of optic neuritis can occur, either in association with other inflammatory disorders or in isolation. Differential diagnosis includes various optic nerve and retinal disorders. Diagnostic investigations include MRI, visual evoked potentials, and CSF examination. Optical coherence tomography can show retinal axonal loss, which correlates with measures of persistent visual dysfunction. Treatment of typical forms with high-dose corticosteroids shortens the period of acute visual dysfunction but does not affect the final visual outcome. Atypical forms can necessitate prolonged immunosuppressive regimens. Optical coherence tomography and visual evoked potential measures are suitable for detection of neuroaxonal loss and myelin repair after optic neuritis. Clinical trials are underway to identify potential neuroprotective or remyelinating treatments for acutely symptomatic inflammatory demyelinating CNS lesions.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24331795     DOI: 10.1016/S1474-4422(13)70259-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  130 in total

Review 1.  Corticosteroids for treating optic neuritis.

Authors:  Robin L Gal; Satyanarayana S Vedula; Roy Beck
Journal:  Cochrane Database Syst Rev       Date:  2015-08-14

Review 2.  Current understanding of the epidemiologic and clinical characteristics of optic neuritis.

Authors:  Masanori Nakazawa; Hitoshi Ishikawa; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2021-05-22       Impact factor: 2.447

3.  Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.

Authors:  Carmen Tur; Olivia Goodkin; Daniel R Altmann; Thomas M Jenkins; Katherine Miszkiel; Alessia Mirigliani; Camilla Fini; Claudia A M Gandini Wheeler-Kingshott; Alan J Thompson; Olga Ciccarelli; Ahmed T Toosy
Journal:  Brain       Date:  2016-02-17       Impact factor: 13.501

Review 4.  [Immunomodulation and neuroprotection in optic neuritis].

Authors:  F Beisse; R Diem
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

5.  Improved Automatic Optic Nerve Radius Estimation from High Resolution MRI.

Authors:  Robert L Harrigan; Alex K Smith; Louise A Mawn; Seth A Smith; Bennett A Landman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-02-24

Review 6.  Distinguishing Susac's syndrome from multiple sclerosis.

Authors:  Katherine A Buzzard; Stephen W Reddel; Con Yiannikas; D Sean Riminton; Michael H Barnett; Todd A Hardy
Journal:  J Neurol       Date:  2014-12-30       Impact factor: 4.849

7.  Role of coronal high-resolution diffusion-weighted imaging in acute optic neuritis: a comparison with axial orientation.

Authors:  Ping Lu; Yan Sha; Hailin Wan; Feng Wang; Guohong Tian
Journal:  Neuroradiology       Date:  2017-06-24       Impact factor: 2.804

Review 8.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

9.  Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis.

Authors:  Wallace J Brownlee; Katherine A Miszkiel; Carmen Tur; Frederik Barkhof; David H Miller; Olga Ciccarelli
Journal:  Neurology       Date:  2018-08-17       Impact factor: 9.910

10.  Retinal and optic nerve degeneration in liver X receptor β knockout mice.

Authors:  Xiao-Yu Song; Wan-Fu Wu; Chiara Gabbi; Yu-Bing Dai; Mark So; Surendra P Chaurasiya; Li Wang; Margaret Warner; Jan-Åke Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.